InsidersTradesSigma
Follow the VECTUS BIOSYSTEMS LIMITED stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares trade on AU AU, under the supervision of ASX. Market capitalisation: €7.7m. The latest transaction was reported on 27 May 2026 (Change in Substantial Holding). Among the most active insiders: Kefford Holdings Pty Ltd ATF The Kefford Family Trust. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
VECTUS BIOSYSTEMS LIMITED is a company listed on the XASX, specializing in the development of biopharmaceutical solutions. It focuses on research and innovation in the field of medical treatments.